Structures and free-energy landscapes of the wild type and mutants of the Abeta(21-30) peptide are determined by an interplay between intrapeptide electrostatic and hydrophobic interactions.

The initial events in protein aggregation involve fluctuations that populate monomer conformations, which lead to oligomerization and fibril assembly. The highly populated structures, driven by a balance between hydrophobic and electrostatic interactions in the protease-resistant wild-type Abeta(21-30) peptide and mutants E22Q (Dutch), D23N (Iowa), and K28N, are analyzed using molecular dynamics simulations. Intrapeptide electrostatic interactions were connected to calculated pK(a) values that compare well with the experimental estimates. The pK(a) values of the titratable residues show that E22 and D23 side chains form salt bridges only infrequently with the K28 side chain. Contacts between E22-K28 are more probable in "dried" salt bridges, whereas D23-K28 contacts are more probable in solvated salt bridges. The strength of the intrapeptide hydrophobic interactions increases as D23N<WT<E22Q<K28A. Free-energy profiles and disconnectivity representation of the energy landscapes show that the monomer structures partition into four distinct basins. The hydrophobic interactions cluster the Abeta(21-30) peptide into two basins, differentiated by the relative position of the DVG(23-25) and GSN(25-27) fragments about the G25 residue. The E22Q mutation increases the population with intact VGSN turn compared to the wild-type (WT) peptide. The increase in the population of the structures in the aggregation-prone Basin I in E22Q, which occurs solely due to the difference in charge states between the Dutch mutant and the WT, gives a structural explanation of the somewhat larger aggregation rate in the mutant. The D23N mutation dramatically reduces the intrapeptide interactions. The K28A mutation increases the intrapeptide hydrophobic interactions that promote population of structures in Basin I and Basin II whose structures are characterized by hydrophobic interaction between V24 and K28 side chains but with well-separated ends of the backbone atoms in the VGSN turn. The intrapeptide electrostatic interactions in the WT and E22Q peptides roughen the free-energy surface compared to the K28A peptide. The D23N mutation has a flat free-energy surface, corresponding to an increased population of random coil-like structures with weak hydrophobic and electrostatic interactions. We propose that mutations or sequences that enhance the probability of occupying Basin I would promote aggregation of Abeta peptides.

[1]  T. C. Hu,et al.  Multi-Terminal Network Flows , 1961 .

[2]  R. Tycko,et al.  Experimental constraints on quaternary structure in Alzheimer's beta-amyloid fibrils. , 2006, Biochemistry.

[3]  D. Otzen,et al.  Designed protein tetramer zipped together with a hydrophobic Alzheimer homology: a structural clue to amyloid assembly. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P. Lansbury,et al.  Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.

[5]  J. Straub,et al.  Probing the origins of increased activity of the E22Q "Dutch" mutant Alzheimer's beta-amyloid peptide. , 2001, Biophysical journal.

[6]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Bashford,et al.  Electrostatic calculations of the pKa values of ionizable groups in bacteriorhodopsin. , 1992, Journal of molecular biology.

[8]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[9]  D. Selkoe,et al.  Title Amyloid β-protein fibrillogenesis . Structure and biological activity of protofibrillar intermediates , 1999 .

[10]  J. Straub,et al.  Charge states rather than propensity for beta-structure determine enhanced fibrillogenesis in wild-type Alzheimer's beta-amyloid peptide compared to E22Q Dutch mutant. , 2002, Protein science : a publication of the Protein Society.

[11]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[12]  K. Iwata,et al.  The Alzheimer's peptide a beta adopts a collapsed coil structure in water. , 2000, Journal of structural biology.

[13]  R. Leapman,et al.  Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. , 2002, Biochemistry.

[14]  T. Morgan,et al.  Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  D. Teplow,et al.  On the nucleation of amyloid β‐protein monomer folding , 2005 .

[16]  D. Craik,et al.  Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? , 1998, Biochemistry.

[17]  M. Karplus,et al.  pKa's of ionizable groups in proteins: atomic detail from a continuum electrostatic model. , 1990, Biochemistry.

[18]  Andrij Baumketner,et al.  Structure of the 21–30 fragment of amyloid β‐protein , 2006 .

[19]  C. Barrow,et al.  Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition. , 1991, Science.

[20]  Francesca Massi,et al.  Structural and dynamical analysis of the hydration of the Alzheimer's β‐amyloid peptide , 2003, J. Comput. Chem..

[21]  H. Stanley,et al.  Folding events in the 21-30 region of amyloid β-protein (Aβ) studied in silico , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. D'Ursi,et al.  Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain. , 2002, European journal of biochemistry.

[23]  J. Straub,et al.  Dynamics of Asp23-Lys28 salt-bridge formation in Abeta10-35 monomers. , 2006, Journal of the American Chemical Society.

[24]  D. Eisenberg,et al.  Analysis of membrane and surface protein sequences with the hydrophobic moment plot. , 1984, Journal of molecular biology.

[25]  K. Beyreuther,et al.  Structure of amyloid A4-(1-40)-peptide of Alzheimer's disease. , 1995, European journal of biochemistry.

[26]  D. Thirumalai,et al.  Emerging ideas on the molecular basis of protein and peptide aggregation. , 2003, Current opinion in structural biology.

[27]  Christine Wurth,et al.  Mutations that reduce aggregation of the Alzheimer's Abeta42 peptide: an unbiased search for the sequence determinants of Abeta amyloidogenesis. , 2002, Journal of molecular biology.

[28]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[29]  M. Karplus,et al.  Hidden complexity of free energy surfaces for peptide (protein) folding. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Straub,et al.  Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution. , 2001, Biophysical journal.

[31]  J. M. Scholtz,et al.  The role of protein stability, solubility, and net charge in amyloid fibril formation , 2003, Protein science : a publication of the Protein Society.

[32]  D. Selkoe,et al.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. , 1999, The Journal of biological chemistry.

[33]  M. Kirkitadze,et al.  Structure determination of micelle-like intermediates in amyloid β-protein fibril assembly by using small angle neutron scattering , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Fabrizio Chiti,et al.  Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  J. Reed,et al.  Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease , 1991 .

[36]  M. Kirkitadze,et al.  Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Hoover,et al.  Canonical dynamics: Equilibrium phase-space distributions. , 1985, Physical review. A, General physics.

[38]  M. Kirkitadze,et al.  Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis. , 2001, Journal of molecular biology.

[39]  R. Stough Solvent and mutation effects on the nucleation of amyloid-protein folding , 2005 .

[40]  Yutaka Ishikawa,et al.  Scientific Computing in Object-Oriented Parallel Environments , 1997, Lecture Notes in Computer Science.

[41]  A. Roher,et al.  Molecular modeling of the Abeta1-42 peptide from Alzheimer's disease. , 1998, Protein engineering.

[42]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[43]  Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[44]  H. Shao,et al.  Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. , 1999, Journal of molecular biology.

[45]  Donald Bashford,et al.  An Object-Oriented Programming Suite for Electrostatic Effects in Biological Molecules , 1997, ISCOPE.

[46]  B. Brooks,et al.  Constant pressure molecular dynamics simulation: The Langevin piston method , 1995 .

[47]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[48]  Christopher M. Dobson,et al.  Kinetic partitioning of protein folding and aggregation , 2002, Nature Structural Biology.

[49]  D. Selkoe,et al.  Alzheimer's Disease: A Central Role for Amyloid , 1994, Journal of neuropathology and experimental neurology.

[50]  R. Riek,et al.  3D structure of Alzheimer's amyloid-β(1–42) fibrils , 2005 .

[51]  Francesca Massi,et al.  Energy landscape theory for Alzheimer's amyloid β‐peptide fibril elongation , 2001 .

[52]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.

[53]  H. Scheraga,et al.  Global optimization of clusters, crystals, and biomolecules. , 1999, Science.

[54]  M. Karplus,et al.  The topology of multidimensional potential energy surfaces: Theory and application to peptide structure and kinetics , 1997 .

[55]  J. Antosiewicz,et al.  Empirical relationships between protein structure and carboxyl pKa values in proteins , 2002, Proteins.

[56]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[57]  R. Leapman,et al.  A structural model for Alzheimer's β-amyloid fibrils based on experimental constraints from solid state NMR , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[58]  V. Uversky Natively unfolded proteins: A point where biology waits for physics , 2002, Protein science : a publication of the Protein Society.

[59]  Sergei V. Krivov,et al.  Free energy disconnectivity graphs: Application to peptide models , 2002 .

[60]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .